ANNAPOLIS, Md., May 9, 2016 - PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the first quarter of 2016.
For the three months ended March 31, 2016,...
